The Receptor Tyrosine Kinase EphA2 Is a Direct Target Gene of Hypermethylated in Cancer 1 (HIC1)
Authors:
- Gaylor BoulayGBGaylor Boulay
- Sébastien PinteSPSébastien Pinte
- Capucine Van RechemCRCapucine Van Rechem
- Brian R. RoodBRBrian R. Rood
- Dominique LeprinceDLDominique Leprince
Open Access
- 1 February 2012
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (8) , 5366-5378
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Ephs and ephrins in cancer: Ephrin-A1 signallingSeminars in Cell & Developmental Biology, 2012
- EphA receptor signaling—Complexity and emerging themesSeminars in Cell & Developmental Biology, 2012
- Loss of a single Hic1 allele accelerates polyp formation in ApcΔ716 miceOncogene, 2011
- Eph receptors and ephrins in cancer: bidirectional signalling and beyondNature Reviews Cancer, 2010
- A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1Oncogene, 2010
- EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with AktCancer Cell, 2009
- HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumorsThe International Journal of Biochemistry & Cell Biology, 2009
- Eph-Ephrin Bidirectional Signaling in Physiology and DiseaseCell, 2008
- The Epigenomics of CancerCell, 2007
- Mechanisms and functions of eph and ephrin signallingNature Reviews Molecular Cell Biology, 2002